Capricor Therapeutics Inc logo

Capricor Therapeutics Inc

$ 5.99 +0.06 (+1.01%) 03:55 PM EST
P/E:
At Loss
P/B:
8.10
Market Cap:
$ 151.50M
Enterprise V:
$ 94.18M
Volume:
246.44K
Avg Vol (2M):
205.70K
Also Trade In:
Volume:
246.44K
Market Cap $:
151.50M
PE Ratio:
At Loss
Avg Vol (2-Month):
205.70K
Enterprise Value $:
94.18M
PB Ratio:
8.10
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Name Current Vs Industry Vs History
Cash-To-Debt 18.77
Equity-to-Asset 0.32
Debt-to-Equity 0.15
Debt-to-EBITDA -0.11
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -6.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63.15
9-Day RSI 58.02
14-Day RSI 57.58
6-1 Month Momentum % 70.09
12-1 Month Momentum % 49.48

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.69
Quick Ratio 2.69
Cash Ratio 2.63

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -97.5

Financials (Next Earnings Date:2022-11-09 Est.)

CAPR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CAPR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.04
Beta 5.3
Volatility % 61.93
14-Day RSI 57.58
14-Day ATR ($) 0.355325
20-Day SMA ($) 5.8425
12-1 Month Momentum % 49.48
52-Week Range ($) 2.56 - 6.21
Shares Outstanding (Mil) 24.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Capricor Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Capricor Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.